The FDA issued a Class 1 recall for two of Medtronic's infusion pumps, according to The Legal Examiner.
The SynchroMed II Implantable and SynchroMed EL Implantable infusion pumps may stall intermittently or completely halt, which can interrupt medications being delivered.
The only drugs approved for use with these pumps are morphine, baclofen, ziconotide, floxuridine and methotrexate. Drugs not approved increase the failure rate of the device from 2.4 percent to 7 percent.
More Articles on Devices:
Omeros Shares Drop 9% After Knee Surgery Clinical Trial Results Released
Aspen Valley Hospital Acquires MAKOplasty Robotic System
Wood May be Suitable Bone Replacement in Orthopedic Implants
The only drugs approved for use with these pumps are morphine, baclofen, ziconotide, floxuridine and methotrexate. Drugs not approved increase the failure rate of the device from 2.4 percent to 7 percent.
More Articles on Devices:
Omeros Shares Drop 9% After Knee Surgery Clinical Trial Results Released
Aspen Valley Hospital Acquires MAKOplasty Robotic System
Wood May be Suitable Bone Replacement in Orthopedic Implants